Atnaujintas knygų su minimaliais defektais pasiūlymas! Naršykite ČIA >>

Regulating Human Embryonic Stem Cell in China: A Comparative Study on Human Embryonic Stem Cell¿s Patentability and Morality in US and EU

-15% su kodu: ENG15
143,97 
Įprasta kaina: 169,38 
-15% su kodu: ENG15
Kupono kodas: ENG15
Akcija baigiasi: 2025-03-03
-15% su kodu: ENG15
143,97 
Įprasta kaina: 169,38 
-15% su kodu: ENG15
Kupono kodas: ENG15
Akcija baigiasi: 2025-03-03
-15% su kodu: ENG15
2025-02-28 169.3800 InStock
Nemokamas pristatymas į paštomatus per 11-15 darbo dienų užsakymams nuo 20,00 

Knygos aprašymas

The general scope of the book is the patentability and morality of human embryonic stem cell research in US, EU and China. The book observes fraudsters operate unsafe human embryonic stem cell therapies and officialdom turns a blind eye to the immoral human embryonic stem cell research in China. The book highlights that both patent control and federal funding control are inefficient and ineffective way to monitoring human embryonic stem cell research. The book finally proposed an approach for china to regulating human embryonic stem cell research-regulating research itself at the reconciled international regime.
The potential reader includes academics and practitioners dealing with intellectual property, patent law and stem cell inventions. The topic discussed will also be interesting to a broad readership, including experts, regulators, policy makers and medical researchers in both ethical and legal disciplines in the field of embryonicstem cell research.

Informacija

Autorius: Li Jiang
Leidėjas: Springer Nature Singapore
Išleidimo metai: 2018
Knygos puslapių skaičius: 220
ISBN-10: 9811095280
ISBN-13: 9789811095283
Formatas: 235 x 155 x 13 mm. Knyga minkštu viršeliu
Kalba: Anglų

Pirkėjų atsiliepimai

Parašykite atsiliepimą apie „Regulating Human Embryonic Stem Cell in China: A Comparative Study on Human Embryonic Stem Cell¿s Patentability and Morality in US and EU“

Būtina įvertinti prekę

Goodreads reviews for „Regulating Human Embryonic Stem Cell in China: A Comparative Study on Human Embryonic Stem Cell¿s Patentability and Morality in US and EU“